Development of a robust LC-MS/MS method for determination of desmosine and isodesmosine in human urine

Journal of Oleo Science

Volumn 59, Issue 8, 2010, Pages 431-439

  Shiraishi, Kohei ^a   Matsuzaki, Kazue ^a   Matsumoto, Akinori ^a   Hashimoto, Yuuki ^a   Iba, Kazuhiko ^a  

^a Sumika Chemicals Analysis Service Ltd   (Japan)

Author keywords

Biomarker; Desmosine; Elastin; Isodesmosine; Tandem mass spectrometry

Indexed keywords

DESMOSINE; ELASTIN; ISODESMOSINE;

ADULT; ARTICLE; BIOLOGICAL MODEL; CALIBRATION; CASE CONTROL STUDY; CHEMISTRY; DRUG STABILITY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LIQUID CHROMATOGRAPHY; LUNG TUMOR; LYMPHANGIOLEIOMYOMATOSIS; MALE; METHODOLOGY; PRODUCTIVITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE; VALIDATION STUDY;

ADULT; CALIBRATION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DESMOSINE; DRUG STABILITY; EFFICIENCY; ELASTIN; FEMALE; HUMANS; ISODESMOSINE; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MALE; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 77954363828     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.59.431     Document Type: Article

References (16)

1. Mahadeva, R.; Shapiro, S. D. Chronic obstructive pulmonary disease. 3: Experimental animal models of pulmonary emphysema. Thorax 57, 908-914(2002).
2. Yoshida, T.; Tuder, R. M. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol. Rev. 87, 1047-1082(2007)
3. Janoff, A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 132, 417-433(1985)
4. Senior, R. M.; Griffin, G. L.; Mecham, R. P. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66, 859-862(1980)
5. Moroy, G.; Alix, A. J.; Hery-Huynh, S. Structural characterization of human elastin derived peptides containing the GXXP sequence. Biopolymers 78, 206-220(2005)
6. Cocci, F.; Miniati, M.; Monti, S.; Cavarra, E.; Gambelli, F.; Battolla, L.; Lucattelli, M.; Lungarella, G. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int. J. Biochem. Cell. Biol. 34, 594-604(2002)
7. Viglio, S.; Iadarola, P.; Lupi A.; Trisolini, R.; Tinelli, C.; Balbi, B.; Grassi, V.; Worlitzsch, D.; Doring, G.; Meloni, F.; Meyer, K.C.; Dowson, L.; Hill, S.L.; Stcokley, R.A.; Luisetti, M. MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur. Respir. J. 15, 1039-1045(2000)
8. Ma, S.; Lieberman, S.; Turino, G. M.; Lin, Y. Y. The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc. Natl. Acad. Sci. U.S.A. 100, 12941-12943(2003)
9. Ma, S.; Lin, Y. Y.; Turino, G. M. Measurements of desmosine and isodesmosine by mass spectrometry in COPD. Chest 131, 1363-1371(2007)
10. Boutin, M.; Berthelette, C.; Gervais, F. G.; Scholand, M. B.; Hoidal, J.; Leppert, M. F.; Bateman, K. P.; Thibault, P. High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine. Anal. Chem. 22, Epub ahead of print(2009)
11. Wren, S. A. Peak capacity in gradient ultra performance liquid chromatograph& UPLC& J. Pharm. Biomed. Anal. 38, 337-343(2005)
12. Castro-Perez, J.; Plumb, R.; Granger, J. H.; Beattie, I.; Joncour, K.; Wright, A. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun. Mass. Spectrom. 19, 843-848(2005)
13. Shen, J. X.; Wang, H.; Tadros, S.; Hayes, R. N. Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25 pg/ mL. J. Pharm. Biomed. Anal. 40, 689-706(2006)
14. Wilson, I. D.; Nicholson, J. K.; Castro-Perez, J.; Granger, J.H.; Johnson, K. A.; Smith, B. W.; Plumb, R. S. High resolution& ultra performance& liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome. Res. 4, 591-598(2005)
15. Churchwell, M. I.; Twaddle, N. C.; Meeker, L. R.; Do-erge, D. R. Improving LC-MS sensitivity through increases in chromatographic performance: Comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 825, 134-143(2005)
16. US Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry-Bioanalytical Method Validation (2001)